nach oben

Current Oncology Reports

Erschienen in:

01.11.2018 | Lung Cancer (H Borghaei, Section Editor)

Palliative Care in Lung Cancer: When to Start

verfasst von: Prianka Bhattacharya, Scott K. Dessain, Tracey L. Evans

Erschienen in: Current Oncology Reports | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Despite recent advances in the care of patients with advanced non-small cell lung cancer (NSCLC), significant morbidity and mortality remains. Symptoms caused by the cancer and its treatments can be profoundly debilitating. Palliative care aims to reduce this burden. In this review, we discuss the definition, purpose, benefits, and optimal timing of palliative care in advanced NSCLC.

Recent Findings

Several studies evaluating the value of early palliative care for patients with advanced NSCLC and other advanced malignancies have identified benefits for patients, caregivers, and health systems.

Summary

For patients with advanced NSCLC, introduction of palliative care early in the disease course improves quality of life and even overall survival. Early institution of palliative care should become standard of care for patients with advanced NSCLC.

SEER Database. Cancer Stat Facts: Lung and Bronchus Cancer. 2018 [cited 2018 4]; Available from: https://seer.cancer.gov/statfacts/html/lungb.html.

Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2016;11(1):39–51. Epub 2016/01/15CrossRef

Wao H, Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Syst Rev. 2013;2:10.CrossRef

Nichols L, Saunders R, Knollmann FD. Causes of death of patients with lung cancer. Arch Pathol Lab Med. 2012;136(12):1552–7.CrossRef

Iyer S, Roughley A, Rider A, Taylor-Stokes G. The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study. Support Care Cancer. 2014;22(1):181–7.CrossRef

World Health Organization. WHO Definition of Palliative Care [cited 2018 4]; Available from: www.who.int/cancer/palliative/definition/en/.

Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, et al. Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol. 2016;17(12):e552–e9.CrossRef

• Dionne-Odom JN, Azuero A, Lyons KD, Hull JG, Tosteson T, Li Z, et al. Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1446–52. Epub 2015/03/25. This study evaluated the effect of timing of palliative care intervention for caregivers, showing the benefit of instituting services earlier rather than later. CrossRef

Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42. Epub 2010/09/08CrossRef

10.

Pirl WF, Temel JS, Billings A, Dahlin C, Jackson V, Prigerson HG, et al. Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. Psychosomatics. 2008;49(3):218–24.CrossRef

11.

Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, et al. Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012;367(17):1616–25. Epub 2012/10/26CrossRef

12.

Temel JS, Greer JA, Admane S, Gallagher ER, Jackson VA, Lynch TJ, et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011;29(17):2319–26. Epub 2011/05/11CrossRef

13.

•• Temel JS, Greer JA, El-Jawahri A, Pirl WF, Park ER, Jackson VA, et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol. 2017;35(8):834–41. This study confirmed the results of the 2010 NEJM study by the same group and expanded the study to patients with advanced GI cancers. CrossRef

14.

• Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721–30. This randomized controlled trial studied benefits of early palliative care intervention in patients with advanced malignancies (including lung, breast, gynecologic, and gastrointestinal malignancies). CrossRef

15.

Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741–9.CrossRef

16.

Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438–45. Epub 2015/03/25CrossRef

17.

NCCN Guidelines. Non-small cell lung Cancer. 2018; Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.

18.

Ford DW, Koch KA, Ray DE, Selecky PA. Palliative and end-of-life care in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e498S–512S.CrossRef

19.

•• Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(1):96–112. Practice guidelines proposed by ASCO for integration of palliative care into care for patients with advanced malignancies. CrossRef

20.

Greer JA, Tramontano AC, McMahon PM, Pirl WF, Jackson VA, El-Jawahri A, et al. Cost analysis of a randomized trial of early palliative care in patients with metastatic nonsmall-cell lung cancer. J Palliat Med. 2016;19(8):842–8.CrossRef

21.

May P, Normand C, Morrison RS. Economic impact of hospital inpatient palliative care consultation: review of current evidence and directions for future research. J Palliat Med. 2014;17(9):1054–63. Epub 2014/07/02CrossRef

22.

Cassel JB, Kerr KM, Kalman NS, Smith TJ. The business case for palliative care: translating research into program development in the U.S. J Pain Symptom Manag. 2015;50(6):741–9. Epub 2015/08/25CrossRef

23.

Triplett DP, LeBrett WG, Bryant AK, Bruggeman AR, Matsuno RK, Hwang L, et al. Effect of palliative care on aggressiveness of end-of-life care among patients with advanced cancer. J Oncol Pract. 2017;13(9):e760–e9. Epub 2017/08/23CrossRef

24.

Humphreys J, Harman S. Late referral to palliative care consultation service: length of stay and in-hospital mortality outcomes. The Journal of Community and Supportive Oncology. 2014;12(4):129–36. Epub 2014/06/28CrossRef

25.

Edens PS, Harvey CD, Gilden KM. Developing and financing a palliative care program. Am J Hosp Palliat Care. 2008;25(5):379–84. Epub 2008/06/10CrossRef

26.

Dumanovsky T, Augustin R, Rogers M, Lettang K, Meier DE, Morrison RS. The growth of palliative care in U.S. hospitals: a status report. J Palliat Med. 2016;19(1):8–15. Epub 2015/09/30CrossRef

27.

von Gunten CF. Secondary and tertiary palliative care in US hospitals. JAMA. 2002;287(7):875–81. Epub 2002/02/20CrossRef

28.

Hui D, Elsayem A, De la Cruz M, Berger A, Zhukovsky DS, Palla S, et al. Availability and integration of palliative care at US cancer centers. JAMA. 2010;303(11):1054–61. Epub 2010/03/18CrossRef

29.

Bickel KE, McNiff K, Buss MK, Kamal A, Lupu D, Abernethy AP, et al. Defining high-quality palliative care in oncology practice: an American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine guidance statement. J Oncol Pract. 2016;12(9):e828–38. Epub 2016/08/18CrossRef

30.

Sweeney CJ, Zhu J, Sandler AB, Schiller J, Belani CP, Langer C, et al. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group study E1594: a phase II trial in patients with metastatic nonsmall cell lung carcinoma. Cancer. 2001;92(10):2639–47. Epub 2001/12/18CrossRef

31.

Brustugun OT, Sprauten M, Helland A. Real-world data on nivolumab treatment of non-small cell lung cancer. Acta Oncol. 2017;56(3):438–40. Epub 2016/11/29CrossRef

32.

Masuda E, Sista AK, Pua BB, Madoff DC. Palliative procedures in lung cancer. Semin Intervent Radiol. 2013;30(2):199–205.CrossRef

33.

NCCN Guidelines. Adult Cancer Pain. 2018 [cited 2018 4]; Available from: https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf.

34.

Guidelines N. Palliative Care. 2018 [cited 2018 4]; Available from: https://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf.

35.

Shih A, Jackson KC 2nd. Role of corticosteroids in palliative care. J Pain Palliat Care Pharmacother. 2007;21(4):69–76.CrossRef

36.

Lossignol D. A little help from steroids in oncology. J Transl Int Med. 2016;4(1):52–4.CrossRef

37.

Farbicka P, Nowicki A. Palliative care in patients with lung cancer. Contemp Oncol (Pozn). 2013;17(3):238–45.

38.

Barnes H, McDonald J, Smallwood N, Manser R. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev. 2016;3:CD011008.PubMed

39.

Galbraith S, Fagan P, Perkins P, Lynch A, Booth S. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manag. 2010;39(5):831–8.CrossRef

40.

Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manag. 2006;31(1):38–47.CrossRef

41.

Wildiers H, Dhaenekint C, Demeulenaere P, Clement PM, Desmet M, Van Nuffelen R, et al. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manag. 2009;38(1):124–33.CrossRef

42.

Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med. 2001;15(4):329–36.CrossRef

43.

Mucke M, Mochamat, Cuhls H, Peuckmann-post V, Minton O, Stone P, et al. Pharmacological treatments for fatigue associated with palliative care: executive summary of a Cochrane Collaboration systematic review. J Cachexia Sarcopenia Muscle. 2016;7(1):23–7. Epub 2016/04/12CrossRef

44.

Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;11:CD006145. Epub 2012/11/16PubMed

45.

• Dionne-Odom JN, Hull JG, Martin MY, Lyons KD, Prescott AT, Tosteson T, et al. Associations between advanced cancer patients' survival and family caregiver presence and burden. Cancer medicine. 2016;5(5):853-62. Epub 2016/02/11. This study identified an adverse effect of increased caregiver burden on patient survival. CrossRef

46.

• Sun V, Grant M, Koczywas M, Freeman B, Zachariah F, Fujinami R, et al. Effectiveness of an interdisciplinary palliative care intervention for family caregivers in lung cancer. Cancer. 2015;121(20):3737-45. This study evaluated benefits of palliative care for caregivers. CrossRef

47.

Wentlandt K, Krzyzanowska MK, Swami N, Rodin GM, Le LW, Zimmermann C. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30(35):4380–6. Epub 2012/10/31CrossRef

48.

Zimmermann C, Swami N, Krzyzanowska M, Leighl N, Rydall A, Rodin G, et al. Perceptions of palliative care among patients with advanced cancer and their caregivers. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 2016;188(10):E217–27. Epub 2016/04/20.CrossRef

49.

Temel JS, McCannon J, Greer JA, Jackson VA, Ostler P, Pirl WF, et al. Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer. 2008;113(4):826–33. Epub 2008/07/12CrossRef

50.

Ersek M, Miller SC, Wagner TH, Thorpe JM, Smith D, Levy CR, et al. Association between aggressive care and bereaved families' evaluation of end-of-life care for veterans with non-small cell lung cancer who died in Veterans Affairs facilities. Cancer. 2017;123(16):3186–94. Epub 2017/04/19CrossRef

51.

Mack JW, Chen K, Boscoe FP, Gesten FC, Roohan PJ, Weeks JC, et al. Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California. J Clin Oncol. 2013;31(20):2569–79.CrossRef

Titel: Palliative Care in Lung Cancer: When to Start
verfasst von: Prianka Bhattacharya
Scott K. Dessain
Tracey L. Evans
Publikationsdatum: 01.11.2018
Verlag: Springer US
Erschienen in: Current Oncology Reports / Ausgabe 11/2018
Print ISSN: 1523-3790
Elektronische ISSN: 1534-6269
DOI: https://doi.org/10.1007/s11912-018-0731-9

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Palliative Care in Lung Cancer: When to Start

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2018

How Intraoperative Tools and Techniques Have Changed the Approach to Brain Tumor Surgery

Pseudoprogression of Melanoma Brain Metastases

The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches

Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors

Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie